Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

Prof Sir John Hardy, Vice President of Alzheimer’s Research UK, outlines how the UK can continue to drive progress towards a ...